Diabetic ketoacidosis (DKA) occurs in 20-40% of children and adolescents with new-onset type 1 diabetes mellitus (T1DM) and after DKA resolves, the therapy is switched to any insulin regimen that aims to control blood glucose (BG) levels. This evidence concerns the gene INS and diabetes mellitus.